Location History:
- Bedminster, NJ (US) (2012)
- Beminster, NJ (US) (2014)
Company Filing History:
Years Active: 2012-2014
Title: The Innovative Mind of Jean Whaley: Pioneering Obesity Treatments
Introduction
Jean Whaley, an accomplished inventor based in Bedminster, NJ, has made significant contributions to the field of medicine, particularly in the treatment of obesity. With two patents to her name, Whaley's research focuses on utilizing SGLT2 inhibitors to facilitate weight loss in mammals, showcasing her commitment to improving health outcomes.
Latest Patents
Among Jean Whaley's notable patents, she has developed methods for treating obesity employing an SGLT2 inhibitor. These innovative methods involve administering a therapeutically effective amount of an SGLT2 inhibitor, either alone or in combination with another anti-obesity agent, to promote weight loss in mammalian subjects. The pharmaceutical compositions she has created also consist of SGLT2 inhibitors paired with suitable carriers, highlighting her inventive approach to tackling obesity.
Career Highlights
Throughout her career, Jean Whaley has worked with prominent companies such as Bristol-Myers Squibb Company and AstraZeneca AB. Her experience in these renowned organizations has undoubtedly contributed to her expertise and success in the field of pharmaceutical innovations.
Collaborations
Collaboration is often key to innovation, and Jean Whaley has worked alongside notable colleagues, including William N. Washburn and James F. List. Their combined efforts in research and development have undoubtedly played a significant role in advancing obesity treatment methodologies.
Conclusion
Jean Whaley is a distinguished inventor whose work in developing methods for treating obesity using SGLT2 inhibitors represents a vital advancement in medical technology. Her collaborations and experiences in industry giants enrich her contributions to the field, paving the way for future innovations in obesity treatment and improving the lives of many.